R

Active Director Director DIN 10989577
DIN 10989577 First appointment Mar 2025 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value •••• Premium profile

About Raseena

Data last updated:

Raseena is a Director at Chani Saanvi Pharma Private Limited (since 2025). The company operates in Non-Profit Organizations. Chani Saanvi Pharma Private Limited reported revenue of ₹7,650 (FY 2024).

DIN 10989577
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 17 Mar 2025
Oldest Company Age 4 yrs
Largest company Chani Saanvi Pharma Private Limited · ₹7,650 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chani Saanvi Pharma Private Limited U85300MP2022PTC062358
Director17 Mar 20252022₹7,650 (FY 2024)Active

Directorship timeline

Open interactive timeline →
Chani Saanvi Pharma Private Limited
Premium access

Shareholding and investment profile for Raseena

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raseena

Raseena currently holds 1 directorship: Chani Saanvi Pharma Private Limited (Director, since 17 Mar 2025, revenue ₹7,650 (FY 2024)).

Raseena was first appointed on 17 Mar 2025 as Director at Chani Saanvi Pharma Private Limited.

The current boards of Raseena's companies include Mahavir Rikhabchand Chhajed (Chani Saanvi Pharma Private Limited), Mohammed Arshad (Chani Saanvi Pharma Private Limited), Suresh Kumar Vaish (Chani Saanvi Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available